Arbele is a biotech and biopharmaceutical company focused on invention of proprietary immunotherapeutic platforms to accelerate the development of “first-in-class” antibody-based biologics to treat gastrointestinal cancers, in particular, stomach, pancreas, colon, bile duct and liver, which remain of high mortality and with limited treatment options.

Our Philosophy

Our Certificates

Academic Network

error: Content is protected !!